Follow
Dr. Virupaksha Bastikar
Dr. Virupaksha Bastikar
Associate Prof. Amity Institute of Biotechnology, Mumbai
Verified email at mum.amity.edu
Title
Cited by
Cited by
Year
Synthesis and molecular modeling studies of 3-chloro-4-substituted-1-(8-hydroxy-quinolin-5-yl)-azetidin-2-ones as novel anti-filarial agents
SS Chhajed, P Manisha, VA Bastikar, H Animeshchandra, VN Ingle, ...
Bioorganic & medicinal chemistry letters 20 (12), 3640-3644, 2010
342010
Potential inhibitory activity of phytoconstituents against black fungus: In silico ADMET, molecular docking and MD simulation studies
NH Hussen, AH Hasan, J Jamalis, S Shakya, S Chander, H Kharkwal, ...
Computational Toxicology 24, 100247, 2022
262022
Structure based design and in-silico molecular docking analysis of some novel benzimidazoles
SS Chhajed, PB Hiwanj, VA Bastikar, CD Upasani, PB Udavant, ...
Int J Chem Tech Res 2 (2), 1135-1140, 2010
212010
Computer aided drug design
SS Chhajed, V Bastikar, AV Bastikar, DK Mahapatra
Pune: Everest Publishing House, 68, 2019
182019
Understanding the Role of Natural Medicinal Compounds Such as Curcumin and Allicin against SARS-CoV-2 Proteins as Potential Treatment against COVID-19: An In silico Approach
VA Bastikar, AV Bastikar, SS Chhajed
Journal of Proteomics & Bioinformatics 13 (7), 2020
102020
CoMFA QSAR models of camptothecin analogues based on the distinctive SAR features of combined ABC, CD and E ring substitutions
B Virupaksha, G Alpana
Computers in biology and medicine 42 (9), 890-897, 2012
102012
Molecular modeling and structure-based drug discovery approach reveals protein kinases as off-targets for novel anticancer drug RH1
PP Gupta, VA Bastikar, D Kuciauskas, SL Kothari, J Cicenas, M Valius
Medical oncology 34, 1-9, 2017
92017
Analysis of naphthoquinone derivatives as topoisomerase I inhibitors using fragment based QSAR
B Virupaksha, G Alpana, K Prashant, D Uday, D Alessandro
Journal of Cheminformatics 5 (Suppl 1), P22, 2013
82013
Quantitative structure–activity relationship-based computational approaches
V Bastikar, A Bastikar, P Gupta
Computational Approaches for Novel Therapeutic and Diagnostic Designing to …, 2022
52022
Molecular dynamics, docking and QSAR analysis of napthoquinone derivatives as topoisomerase I inhibitors
S Kulkarni, P Patil, B Virupaksha, G Alpana, K Prashant, S Baikerikar
Int J Comput Bioinfo In Silico 2 (5), 223-233, 2013
42013
Virulence prediction model (virprob) using amino acid and dipeptide composition for human pathogens
SB Muley, V Bastikar, S Bothe, A Meshram, N Roy
Journal of Biophysics and Structural Biology 3 (1), 24-29, 2011
42011
Synthesis, physicochemical properties and biological evaluation of some novel 5-[2-methyl/(un) substituted phenylethylideneamino] quinolin-8-ols.
SS Chhajed, CD Upasani, VA Bastikar, NP Mahajan
42010
Estimation of quetiapine in bulk drug and tablet dosage form
SS Chhajed, SS Agrawal, VA Bastikar, RA Gosavi, SH Kunte, RD Wagh
International Journal of Chemical Sciences 7 (2), 951-960, 2009
42009
In silico docking analysis of peptide deformylase (PDF)-a novel target for prophylaxis of leptospirosis
V Bastikar, S Fulsundar, J Nair
Nature Precedings, 1-1, 2008
42008
Computational screening techniques for Lead design and development
PP Gupta, VA Bastikar, A Bastikar, SS Chhajed, PA Pathade
Computer-aided drug design, 187-222, 2020
22020
Chemical Structure Databases in Drug Discovery
PP Gupta, VA Bastikar, SS Chhajed
Computer Applications in Drug Discovery and Development, 47-61, 2019
22019
Homology Modeling: Applications in the Low Molecular Weight Ligand Designing
SS Chhajed, PP Gupta, VA Bastikar, V Patil
Biologically Active Small Molecules, 273-284, 2023
12023
Hepatitis C virus and hepatocellular carcinoma
PP Gupta, VJ Sadrani, PP Gupta, MM Parab, VA Bastikar
Oncogenic Viruses, 243-262, 2023
12023
Characterization of Human-malarial Parasite Species based on DHFR and GST Targets Resulting in Changes in Anti-malarial Drug Binding Conformations
S Sakpal, SL Kothari, V Bastikar
Drug Metabolism and Bioanalysis Letters Formerly: Drug Metabolism Letters 15 …, 2022
12022
Targeting SARS-CoV2 Main Protease using HTVS and simulation analysis: A drug repurposing approach against COVID-19
VA Bastikar, P Gupta, AV Bastikar, SS Chhajed
MDPI, 2020
12020
The system can't perform the operation now. Try again later.
Articles 1–20